Could a sleep aid also ease Parkinson's movement problems?

NCT ID NCT07384429

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether the sleep medication lemborexant can improve both sleep and motor symptoms in people with Parkinson's disease. Forty-four participants will take either lemborexant or a placebo nightly for 28 days. Researchers will measure changes in sleep quality and movement ability using standard Parkinson's rating scales.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
lemborexant
What this could lead to
If it works, this could point toward a new way to help Parkinson's patients sleep better and possibly move more easily during the day.
What could go wrong
This is a small, early-phase trial with only 44 people. It may not show clear benefits, and lemborexant can cause side effects like drowsiness or dizziness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INSOMNIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Zhongnan hospital

    Wuhan, Hubei, 430000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.